Nuveen
COCP icon

Nuveen’s Cocrystal Pharma COCP Stock Holding History

Nuveen’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.14K Buy
+1,909
New +$2.04K ﹤0.01% 4839

Other funds holding COCP

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Parallel Advisors
Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return
Clean Yield Group
Clean Yield Group Norwich, Vermont $412M AUM 20.54% 1-Year Est. Return
NVWM LLC
NVWM LLC Yardley, Pennsylvania $533M AUM 27.53% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Nuveen's COCP Position: Q3 2026 in Review

Nuveen opened a new position in Cocrystal Pharma (COCP) in Q3 2026: 1,909 shares worth $2.14K. The stake represents ﹤0.01% of the portfolio and ranks #4839 among its holdings.

8 funds tracked by Wall St. Rank hold COCP as of Q3 2026.

  • Nuveen held 1,909 shares of Cocrystal Pharma worth $2.14K as of Q3 2026.
  • Cocrystal Pharma was a new Nuveen position in Q3 2026.
  • Cocrystal Pharma made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4839 holding.
  • 8 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.